JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Protagonist Therapeutics (PTGX – Research Report) today and set a price ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...

Roku Inc. (NASDAQ:ROKU) posted excellent fiscal third-quarter 2024 results, exceeding $1 billion in total net sales for the ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

PJT Partners (NYSE:PJT – Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $152.00 to $177.00 in a report issued on Wednesday,Benzinga reports.

AI is evolving rapidly with recent breakthroughs making it more accessible and efficient than ever. Smaller, cost-effective ...

The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain ...

Full-year 2024 core EPS reached $3.18, more than double the 2023 results, with a core return on equity of 8.8%. She highlighted that the company has fully restored Property & Casualty profitability, ...

We recently compiled a list of the 10 Trending AI Stocks on Wall Street’s Radar. In this article, we are going to take a look ...

Even with its well-documented benefits, DoE is often underutilised, especially for solving specialised or constrained ...